MENU
APGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Apogee Therapeutics (APGE) Ownership - Who owns Apogee Therapeutics?

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications... Show more

Profile

Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
261
Web
https://www.apogeetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.81B
P/E Ratio
N/A
Total Cash
1.06B
Projected Growth
N/A
Total Debt
8.05M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
14.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
APGE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
261
Web
https://www.apogeetherapeutics.com